Association of Endocrine Therapy for HR+/<i>ERBB2</i>+ Metastatic Breast Cancer With Survival Outcomes

Marcela Carausu, Matthieu Carton, Véronique Diéras, Thierry Petit, Séverine Guiu, Anthony Gonçalves, Paule Augereau, Jean Marc Ferrero, Christelle Levy, Mony Ung, Isabelle Desmoulins, Marc Debled, Thomas Bachelot, Barbara Pistilli, Jean-Sébastien Frenel, Audrey Mailliez, Michaël Chevrot, Luc Cabel

Open source

DOI: 10.1001/jamanetworkopen.2022.47154
Published: 2022-12-15
Container: JAMA Network Open
Publisher: American Medical Association (AMA)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1001/jamanetworkopen.2022.47154,
  title = {Association of Endocrine Therapy for HR+/<i>ERBB2</i>+ Metastatic Breast Cancer With Survival Outcomes},
  author = {Marcela Carausu and Matthieu Carton and Véronique Diéras and Thierry Petit and Séverine Guiu and Anthony Gonçalves and Paule Augereau and Jean Marc Ferrero and Christelle Levy and Mony Ung and Isabelle Desmoulins and Marc Debled and Thomas Bachelot and Barbara Pistilli and Jean-Sébastien Frenel and Audrey Mailliez and Michaël Chevrot and Luc Cabel},
  year = {2022},
  journal = {JAMA Network Open},
  doi = {10.1001/jamanetworkopen.2022.47154},
  url = {https://doi.org/10.1001/jamanetworkopen.2022.47154}
}

RIS

TY  - JOUR
TI  - Association of Endocrine Therapy for HR+/<i>ERBB2</i>+ Metastatic Breast Cancer With Survival Outcomes
AU  - Marcela Carausu
AU  - Matthieu Carton
AU  - Véronique Diéras
AU  - Thierry Petit
AU  - Séverine Guiu
AU  - Anthony Gonçalves
AU  - Paule Augereau
AU  - Jean Marc Ferrero
AU  - Christelle Levy
AU  - Mony Ung
AU  - Isabelle Desmoulins
AU  - Marc Debled
AU  - Thomas Bachelot
AU  - Barbara Pistilli
AU  - Jean-Sébastien Frenel
AU  - Audrey Mailliez
AU  - Michaël Chevrot
AU  - Luc Cabel
PY  - 2022
JO  - JAMA Network Open
DO  - 10.1001/jamanetworkopen.2022.47154
UR  - https://doi.org/10.1001/jamanetworkopen.2022.47154
ER  -

APA

Carausu, M., Carton, M., Diéras, V., Petit, T., Guiu, S., Gonçalves, A., Augereau, P., Ferrero, J. M., Levy, C., Ung, M., Desmoulins, I., Debled, M., Bachelot, T., Pistilli, B., Frenel, J., Mailliez, A., Chevrot, M., & Cabel, L. (2022). Association of Endocrine Therapy for HR+/<i>ERBB2</i>+ Metastatic Breast Cancer With Survival Outcomes. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2022.47154

Source records

crossref · retrieved 2026-09-25T04:13:40.855Z